Patents by Inventor John J. Wright

John J. Wright has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7591133
    Abstract: A block manifold for a fail safe actuator system allows the actuator operation with a hand pump if electrical power were not available. A method is available to isolate fail safe solenoid valves and an accumulator from a hand pump circuit to relieve the stored energy from the fail safe circuit. An additional set of pilot operated check valves were installed between the motor driven pump circuit and the hand pump circuit. These pilot operated check valves isolated the hand pump circuit from the fail safe dump solenoid and accumulator. These pilot actuated check valves also hold the actuator in the fail safe position as long as the hand pump system was not used. There is also a hydraulic bleed circuit to relieve the accumulator stored energy when the hand pump system was used.
    Type: Grant
    Filed: January 3, 2006
    Date of Patent: September 22, 2009
    Inventor: John J. Wright
  • Patent number: 7582661
    Abstract: Compounds are provided that act as potent antagonists of the CCR9 receptor, and which have been further confirmed in animal testing for inflammation, one of the hallmark disease states for CCR9. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR9-mediated diseases, and as controls in assays for the identification of CCR9 antagonists.
    Type: Grant
    Filed: January 27, 2005
    Date of Patent: September 1, 2009
    Assignee: ChemoCentryx, Inc.
    Inventors: Solomon Ugashe, Zheng Wei, John J. Wright, Andrew Pennell
  • Publication number: 20080292616
    Abstract: Disclosed are topical compositions comprising at least one histone deacetylase (HDAC) inhibitor (HDI) and a carrier comprising petrolatum. Methods for using such compositions to treat or inhibit cancer and various skin diseases are also disclosed.
    Type: Application
    Filed: August 15, 2006
    Publication date: November 27, 2008
    Applicant: Government of the United of America, Represented by the Secretary, Department of Health and....
    Inventors: Susan E. Bates, Antonio Tito Fojo, Richard L. Piekarz, John J. Wright, George J. Grimes, Karen M. Schweikart
  • Patent number: 7437712
    Abstract: A system for managing software builds is provided. The system comprises a code control system operable to maintain a code version and a information associated with the code version, a parser module in communication with the code control system, the parser module operable to parse the information associated with the code version and create a change report, and a compiler module in communication with the code control system and operable to compile the code version into an object version based on the change report. A method of managing software builds is also provided. A method for building a software version is also provided.
    Type: Grant
    Filed: January 22, 2004
    Date of Patent: October 14, 2008
    Assignee: Sprint Communications Company L.P.
    Inventors: Bobby B. Brown, Shawn M. Hudson, John J. Wright
  • Patent number: 7335653
    Abstract: Compounds are provided that act as potent antagonists of chemokine receptors. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of chemokine receptor-mediated diseases, and as controls in assays for the identification of chemokine antagonists.
    Type: Grant
    Filed: April 23, 2007
    Date of Patent: February 26, 2008
    Assignee: ChemoCentryx, Inc.
    Inventors: Solomon Ungashe, Zheng Wei, John J. Wright, Andrew Pennell, Brett Permack, Thomas Schall
  • Publication number: 20070066583
    Abstract: Compounds are provided that act as potent antagonists of the CCR1 receptor, and have in vivo anti-inflammatory activity. The compounds are generally monocyclic and bicyclic compounds and are useful in pharmaceutical compositions, methods for the treatment of CCR1-mediated diseases, and as controls in assays for the identification of competitive CCR1 antagonists.
    Type: Application
    Filed: August 14, 2006
    Publication date: March 22, 2007
    Applicant: ChemoCentryx, Inc.
    Inventors: Penglie Zhang, Andrew Pennell, John J. Wright, Lianfa Li, Edward Sullivan, Wei Chen, Kevin Lloyd Greenman
  • Publication number: 20070021484
    Abstract: Substituted benzamide compounds are provided along with methods for the use of those compounds for treating cancer.
    Type: Application
    Filed: June 28, 2006
    Publication date: January 25, 2007
    Applicant: ChemoCentryx, Inc.
    Inventors: Anita Melikian, John J. Wright, Antoni Krasinski
  • Publication number: 20070010524
    Abstract: Compounds are provided that act as potent antagonists of the CCR1 receptor, and have in vivo anti-inflammatory activity. The compounds are generally aryl piperazine derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR1-mediated diseases, and as controls in assays for the identification of competitive CCR1 antagonists.
    Type: Application
    Filed: June 22, 2006
    Publication date: January 11, 2007
    Applicant: ChemoCentryx, Inc.
    Inventors: Penglie Zhang, Andrew Pennell, John J. Wright, Wei Chen, Manmohan Leleti, Yandong Li, Lianfa Li, Yuan Xu
  • Publication number: 20070010523
    Abstract: Compounds are provided that act as potent antagonists of the CCR1 receptor, and have in vivo anti-inflammatory activity. The compounds are generally aryl piperazine derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR1-mediated diseases, and as controls in assays for the identification of competitive CCR1 antagonists.
    Type: Application
    Filed: June 22, 2006
    Publication date: January 11, 2007
    Applicant: ChemoCentryx, Inc.
    Inventors: Penglie Zhang, Andrew Pennell, John J. Wright, Wei Chen, Manmohan Leleti, Matthew Ronsheim
  • Publication number: 20060074071
    Abstract: Substituted benzamide compounds are provided along with methods for the use of those compounds for treating cancer.
    Type: Application
    Filed: August 11, 2005
    Publication date: April 6, 2006
    Applicant: ChemoCentryx, Inc.
    Inventors: Anita Melikian, John J. Wright
  • Patent number: 6472869
    Abstract: A diode laser-pumped magnetometer includes a diode laser that emits a polarized pumping laser beam with resonant optical radiation; and a K-cell through which a magnetic field is manifested from an independent source, the K-cell containing atoms with a dipole experiencing a torque due to the magnetic field. The atoms are excited by the resonant optical radiation of the pumping laser beam and periodically emitting a response radiation as they return to ground state such that the response radiation includes photons that indicate one unit of angular momentum indicative of the torque due to the magnetic field. Finally, a photodetector serves as a means for measuring the response radiation of the K-cell to indicate thereby a measure of the magnetic field in the K-cell from the independent magnetic source.
    Type: Grant
    Filed: June 18, 2001
    Date of Patent: October 29, 2002
    Assignee: United States of America as represented by the Secretary of the Air Force
    Inventors: Bernard L. Upschulte, Steven J. Davis, Ludwig C. Balling, John J. Wright
  • Patent number: 6455575
    Abstract: The present invention concerns antitumor compounds. More particularly, the invention provides novel taxane derivatives, pharmaceutical compositions thereof, and their use as antitumor agents.
    Type: Grant
    Filed: June 6, 1997
    Date of Patent: September 24, 2002
    Assignee: Bristol-Myers Squibb Company
    Inventors: Jerzy Golik, Dolatrai Vyas, John J. Wright, Henry Wong, John F. Kadow, John K. Thottathil, Wen-Sen Li, Murray A. Kaplan, Robert K. Perrone, Mark D. Wittman
  • Publication number: 20010023255
    Abstract: The present invention concerns antitumor compounds. More particularly, the invention provides novel taxane derivatives, pharmaceutical compositions thereof, and their use as antitumor agents.
    Type: Application
    Filed: June 6, 1997
    Publication date: September 20, 2001
    Inventors: JERZY GOLIK, DOLATRAI VYAS, JOHN J. WRIGHT, HENRY WONG, JOHN F. KADOW, JOHN K. THOTTATHIL, WEN-SEN LI, MURRAY A. KAPLAN, ROBERT K. PERRONE, MARK D. WITTMAN
  • Patent number: 6170193
    Abstract: An in-ground flower holder is provided with a body having a top opening defined by a planar or flanged area and a lower opening passage through which water may flow. An insert is located within the interior of the body, the insert having a gripping area which allows access to the insert by a user when the flower holder is embedded within the ground. A base of the insert is used to carry flowers placed within the body. A bottom surface of a base of the insert carries a plug member which is adapted to substantially a similar size as an opening formed as a funnel in the bottom of the body. When in one holding position, the plug and funnel form a watertight seal thereby holding any water within the interior. When the insert is moved to another position, the watertight seal is broken and a passage for water out of the interior is provided. A lock maintains the insert within the interior of the body. Additionally, the upper surface of the body or of the lock is configured such that indicia may be placed thereon.
    Type: Grant
    Filed: December 31, 1998
    Date of Patent: January 9, 2001
    Assignee: Catholic Cemeteries Association of The Diocese of Cleveland
    Inventors: John J. Wright, Frank W. Was
  • Patent number: 5768149
    Abstract: A design system for designing a tube for a gas turbine engine is described. The system including, in one embodiment, a computer workstation having a plurality of executable modules stored therein. The modules include a tube design module for routing a tube between tube fittings, a tube editing module for editing tube assembly geometry, and a tube detailing module for preparing detail drawings.
    Type: Grant
    Filed: December 20, 1995
    Date of Patent: June 16, 1998
    Assignee: General Electric Company
    Inventors: Michael A. Umney, John J. Wright, Eric G.V. Hall, Kenneth J. Ashton
  • Patent number: 5689435
    Abstract: A design system for designing brackets for gas turbine engines is described. The system may be implemented with a computer workstation and includes a part model library and a drawing note library. The computer workstation is configured to receive a bracket model in electronic form as input and has a number of executable modules stored therein. The system outputs a bracket master model and detail drawings. In one embodiment, the modules include a bracket intelligence builder module for generating intelligence data for the bracket model, a bracket unfolding module for unfolding a bracket model to a flat pattern, a bracket folding module to fold a bracket flat pattern, and a bracket minimum material check module to check for minimum distances between bracket pattern features. Other modules also are described and may form a elements of the system.
    Type: Grant
    Filed: February 20, 1997
    Date of Patent: November 18, 1997
    Assignee: General Electric Company
    Inventors: Michael A. Umney, John J. Wright, James S. Hoelle, Michael S. Godbey, Eric G. V. Hall, Kenneth J. Ashton
  • Patent number: 5686426
    Abstract: There is provided a novel series of O-carboxymethylated .alpha.- and .beta.-glycolipid compounds of the formula ##STR1## wherein R is an acyl residue of a fatty acid;R.sup.1 is --(CH.dbd.CH).sub.m --(CH.sub.2).sub.n --CH.sub.3 ;R.sup.2, R.sup.3, R.sup.4 R.sup.5 and R.sup.6 each are independently hydrogen, unsubstituted or substituted alkanoyl, arylalkyl or arylcarbonyl wherein said substituent is selected from halogen, C.sub.1-4 alkyl, trifluoromethyl, hydroxy and C.sub.1-4 alkoxy;R.sup.3, R.sup.4 and R.sup.6 each are independently --CH.sub.2 COOR.sup.7, provided at least two of the R.sup.3, R.sup.4 and R.sup.6 substituents are --CH.sub.2 COOR.sub.7 ;m is an integer of 0 or 1;n is an integer of from 5 to 14, inclusive; andR.sup.
    Type: Grant
    Filed: November 17, 1994
    Date of Patent: November 11, 1997
    Assignee: Bristol-Myers Squibb Company
    Inventors: Alain Martel, John J. Wright
  • Patent number: 5646176
    Abstract: The present invention concerns antitumor compounds. More particularly, the invention provides novel taxane derivatives, pharmaceutical compositions thereof, and their use as antitumor agents.
    Type: Grant
    Filed: May 19, 1995
    Date of Patent: July 8, 1997
    Assignee: Bristol-Myers Squibb Company
    Inventors: Jerzy Golik, Dolatrai Vyas, John J. Wright, Henry Wong, John F. Kadow, John K. Thottathil, Wen-Sen Li, Murray A. Kaplan, Robert K. Perrone, Mark D. Wittman
  • Patent number: 5627192
    Abstract: The present invention relates to novel dihydroquinolines which are useful for cholesterol lowering and as antioxidant agents. Also provided is a process for preparing the dihydroquinolines of the present invention, pharmaceutical compositions, and a method of treating or inhibiting hypercholesterolemia, hyperlipidemia, atherosclerosis, and LDL oxidation which comprises administering to birds and mammals in need of such treatment an effective amount of a compound of the present invention.
    Type: Grant
    Filed: March 15, 1995
    Date of Patent: May 6, 1997
    Assignee: Bristrol-Myers Squibb Company
    Inventors: Bradley C. Pearce, John J. Wright
  • Patent number: D479576
    Type: Grant
    Filed: November 7, 2002
    Date of Patent: September 9, 2003
    Assignee: Marine and Industrial Hydraulics, Inc.
    Inventor: John J. Wright